Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Kemperman, C.J.F.
and
van den Hoofdakker, R.H.
1990.
Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up—a case report.
European Neuropsychopharmacology,
Vol. 1,
Issue. 1,
p.
67.
Ebadi, M.
Pfeiffer, R.F.
and
Murrin, L.C.
1990.
Pathogenesis and treatment of neuroleptic malignant syndrome.
General Pharmacology: The Vascular System,
Vol. 21,
Issue. 4,
p.
367.
NIMMO, S. M.
KENNEDY, B. W.
TULLETT, W. M.
BLYTH, A. S.
and
DOUGALL, J. R.
1993.
Drug‐induced hyperthermia.
Anaesthesia,
Vol. 48,
Issue. 10,
p.
892.
Lev, Roneet
and
Clark, Richard F.
1994.
Neuroleptic malignant syndrome presenting without fever: Case report and review of the literature.
The Journal of Emergency Medicine,
Vol. 12,
Issue. 1,
p.
49.
Erermis, Serpil
Bildik, Tezan
Tamar, Muge
Gockay, Ahmet
Karasoy, Hatice
and
Ercan, Eyup Sabri
2007.
Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl.
Clinical Toxicology,
Vol. 45,
Issue. 3,
p.
277.
Menager, C.
Boimond, N.
and
Cheron, G.
2013.
Intoxication au zuclopenthicol benzoate : mise en évidence par chromatographie.
Archives de Pédiatrie,
Vol. 20,
Issue. 3,
p.
286.
2016.
Meyler's Side Effects of Drugs.
p.
609.
Shouan, Anish
Sinha, AnkitKumar
and
Grover, Sandeep
2020.
Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate.
Industrial Psychiatry Journal,
Vol. 29,
Issue. 2,
p.
349.
eLetters
No eLetters have been published for this article.